Currently out of the existing stock ratings of Michael Okunewitch, 30 are a BUY (90.91%), 3 are a HOLD (9.09%).

Michael Okunewitch

Work Performance Price Targets & Ratings Chart

Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 23.89% that have a potential upside of 48.12% achieved within 93 days. Previously, Michael Okunewitch worked at BARCLAYS.

Michael Okunewitch’s has documented 59 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BRTX, BioRestorative Therapies at 06-Oct-2026.

Wall Street Analyst Michael Okunewitch

Analyst best performing recommendations are on LGVN (LONGEVERON LLC).
The best stock recommendation documented was for LGVN (LONGEVERON LLC) at 3/24/2022. The price target of $1400 was fulfilled within 8 days with a profit of $688 (96.63%) receiving and performance score of 120.79.

Average potential price target upside

ATAI ATAI Life Sciences BV CTXR Citius Pharmaceuticals KPRX Kiora Pharmaceuticals BRTX BioRestorative Therapies ANEB Anebulo Pharmaceuticals CMMB Chemomab Therapeutics Ltd DRC HCWB HCW Biologics LGVN Longeveron LLC GILD Gilead Sciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Mar-2026

$8

$0.65 (8.84%)

$12

2 months 9 days ago
(12-Aug-2026)

0/2 (0%)

$0.77 (10.65%)

Buy Since 18-Oct-2021

$7.5

$0.15 (2.04%)

$25

3 months 1 days ago
(20-Jul-2026)

0/16 (0%)

$0.31 (4.31%)

Buy Since 15-Jan-2026

$16

3 months 4 days ago
(17-Jul-2026)

0/2 (0%)

$12.43 (348.18%)

Buy Since 01-Sep-2021

$7.5

$0.15 (2.04%)

3 months 4 days ago
(17-Jul-2026)

0/3 (0%)

$0.28 (3.88%)

Buy Since 19-Jan-2026

$16

3 months 4 days ago
(17-Jul-2026)

0/4 (0%)

$11.91 (291.20%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Michael Okunewitch most bullish on?

Potential upside of $28.76 has been obtained for HCWB (HCW BIOLOGICS)

Which stock is Michael Okunewitch most reserved on?

Potential downside of -$0 has been obtained for ATAI (ATAI LIFE SCIENCES BV)

What Year was the first public recommendation made by Michael Okunewitch?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?